COMPANY
RLMD
NASDAQ
Relmada Therapeutics, Inc.
STOCK RANK
897 / 3601
(Lower rank = stronger performance)
RECOMMENDATION
Hold
RANK TREND
COMPONENT RANKS
Component ranks (lower = stronger). The overall stock rank blends these inputs.
Overall
897
Model 1
661
Model 2
3102
Model 3
517
July 2026 (Current) Rankings Summary: July 2026 · Published July 31, 2026
July 2026 (Current) Rankings Summary · Historical performance · Methodology